DeJohn, C. A., Veronneau, S. J. H., Wolbrink, A. M., Larcher, J. G., Smith, D. W., & Garrett, J. (2000). The Evaluation of In-Flight Medical Care Aboard Selected U.S. Air Carriers: 1996 to 1997 (Report No. DOT/FAA/AM-00/13). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/57921
DeJohn, C. A., S. J. H. Veronneau, A. M. Wolbrink, J. G. Larcher, D. W. Smith, and J Garrett. The Evaluation of In-Flight Medical Care Aboard Selected U.S. Air Carriers: 1996 to 1997. Report no. DOT/FAA/AM-00/13. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2000. https://rosap.ntl.bts.gov/view/dot/57921.
DeJohn, C. A., et al. The Evaluation of In-Flight Medical Care Aboard Selected U.S. Air Carriers: 1996 to 1997. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2000, Report no. DOT/FAA/AM-00/13, ROSA P. https://rosap.ntl.bts.gov/view/dot/57921.
Medical care in-flight and the FAA-mandated medical kit have been studied for many years. This study includes a detailed correlation between in-flight medical care, patient response in-flight, and post-flight follow-up, in an effort to evaluate in-flight medical care delivery on US airlines and re-evaluate the FAA-mandated in-flight medical kit. A survey of five US domestic air carriers from October 1, 1996, to September 30, 1997, showed 1132 in-flight medical incidents. These airlines accounted for approximately 22% of scheduled US domestic enplanements during the period. There was good overall agreement between in-flight and post-flight diagnoses (70% of cases), and passenger condition improved in a majority of cases (60%), suggesting that in-flight diagnoses were generally accurate and treatment was appropriate. Results indicated that bronchodilator inhalers, oral antihistamines, and non-narcotic analgesics, all of which were obtained from other passengers, were used frequently enough to support a suggestion to include them in the medical kit.
DeJohn, C. A., Veronneau, S. J. H., Wolbrink, A. M., Larcher, J. G., Smith, D. W., & Garrett, J. (2000). The Evaluation of In-Flight Medical Care Aboard Selected U.S. Air Carriers: 1996 to 1997 (Report No. DOT/FAA/AM-00/13). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/57921
DeJohn, C. A., S. J. H. Veronneau, A. M. Wolbrink, J. G. Larcher, D. W. Smith, and J Garrett. The Evaluation of In-Flight Medical Care Aboard Selected U.S. Air Carriers: 1996 to 1997. Report no. DOT/FAA/AM-00/13. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2000. https://rosap.ntl.bts.gov/view/dot/57921.
DeJohn, C. A., et al. The Evaluation of In-Flight Medical Care Aboard Selected U.S. Air Carriers: 1996 to 1997. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2000, Report no. DOT/FAA/AM-00/13, ROSA P. https://rosap.ntl.bts.gov/view/dot/57921.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.